Daniel Trachsel

Daniel Trachsel
EducationBurgdorf University of Applied Sciences
OccupationMedicinal chemist
Years active1993–present
Organization(s)ReseaChem GmbH, MindShift
Known forWork on psychedelics and other psychoactive drugs
Notable workPsychedelische Chemie Aspekte Psychoaktiver Moleküle (2000); Phenethylamine: von der Struktur zur Funktion (2013)
Websitehttps://nachtschatten.ch/autoren/trachsel/

Daniel Trachsel is a Swiss medicinal chemist who is known for working in the pharmaceutical industry and for studying and developing numerous psychedelics and other psychoactive drugs.

Biography

Trachsel studied chemistry at the Burgdorf University of Applied Sciences. He became interested in psychoactive drugs in 1993, which coincided with the start of his training as a chemist.

Trachsel published his first book, Psychedelische Chemie Aspekte Psychoaktiver Moleküle (Psychedelic Chemistry: Aspects of Psychoactive Molecules), in 2000, which has undergone several revisions. He also published the book Phenethylamine: Von der Struktur zur Funktion (Phenethylamines: From Structure to Function), co-authored with David Lehmann and Christoph Enzensperger, in 2013. According to Hamilton Morris and Nick Cozzi in mid-2023, this book is in the process of being translated into English. It is being translated by the Alexander Shulgin Research Institute (ASRI), with tentative publication by Transform Press, and is also independently being translated by chemist David Carlson.

Trachsel worked as a medicinal chemist at a biopharmaceutical company starting in 2002, including in areas like renin inhibitors and orexin receptor antagonists. He is the head of chemistry at ReseaChem GmbH, a chemical research laboratory, in Burgdorf, Switzerland. In addition to his books and papers, Trachsel has published various patents, including many on psychedelics with Matthias Liechti and others that have been assigned to Mind Medicine (now Definium Therapeutics).

Trachsel has developed and published on a large number of novel psychedelic and entactogen compounds, including their psychoactive effects. This has been in a manner similar to that of the psychedelic chemist Alexander Shulgin, which has caused Trachsel to sometimes be referred to as the "German Shulgin". However, unlike Shulgin, Trachsel has publicly distanced himself from self-experimentation. Trachsel has especially studied fluorinated and other phenethylamines, for instance the mescaline derivative trifluoromescaline (TFM), among many others.

Compounds

Compounds that were first synthesized, tested in humans, and/or reported by Trachsel and colleagues include:

Selected publications

Books

  • Trachsel, D.; Richard, N. (2000). Psychedelische Chemie Aspekte Psychoaktiver Moleküle [Psychedelic Chemistry: Aspects of Psychoactive Molecules] (in German) (1 ed.). Nachtschatten-Verlag. ISBN 978-3-907080-53-5. OCLC 247657972. Archived from the original on 18 October 2025. [Note: There are also several subsequent editions (2nd (2002) through 5th (2016)).]
  • Trachsel, D.; Lehmann, D.; Enzensperger, C. (2013). Phenethylamine: von der Struktur zur Funktion [Phenethylamines: From Structure to Function]. Nachtschatten-Science (in German) (1 ed.). Solothurn: Nachtschatten-Verlag. ISBN 978-3-03788-700-4. OCLC 858805226. Archived from the original on 21 August 2025.

Papers

See also